Basic Information
Basic information for UCA1-233-31aa
Peptide Name UCA1-233-31aa
Genome Position chr19:15835041-15835114,15835218-15835236[+]
Species Human
Peptide Sequence MDNSTRIWGQFHIFGNQTSIQDNTKICNQNY
Peptide Length 31
Unique No (UCA1-202-31aa,UCA1-203-31aa,UCA1-210-31aa,UCA1-211-31aa,UCA1-214-31aa,UCA1-216-31aa,UCA1-220-31aa,UCA1-221-31aa,UCA1-229-31aa,UCA1-231-31aa,UCA1-234-31aa,UCA1-237-31aa,UCA1-243-31aa,UCA1-244-31aa)
Grand Average of Hydropathicity -0.929
Relative Molecular Mass 4215.59
Experimental Evidences 3:lncORF,m6A,ribo
lncRNA ID/Name ENSG00000214049;UCA1
Transcript ID/Name ENST00000646397;UCA1-233
Transcript Length 1215
Coding Ability 0.5695
DNA Sequence Corresponding to Peptide ATGGACAACAGTACACGCATATGGGGCCAGTTCCACATATTTGGCAACCAGACCAGCATCCAGGACAACACAAAGATCTGCAATCAGAACTAT
Experimental Evidences
   lncORF
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :